Opus Genetics Correlations

IRD Stock

3.58 0.08 2.29%

The current 90-days correlation between Opus Genetics and Takeda Pharmaceutical Co is -0.05 (i.e., Good diversification). The correlation of Opus Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Opus Genetics Correlation With Market

Very weak diversification

The correlation between Opus Genetics and DJI is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Opus Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.

Moving together with Opus Stock

0.79	AMG	Amgen Inc	Pair Corr
0.78	RO	Roche Holding AG	Pair Corr
0.78	RHO6	Roche Holding	Pair Corr
0.81	H6D	Haleon PLC	Pair Corr
0.9	PFE	Pfizer Inc CDR	Pair Corr
0.85	PFE	Pfizer Inc	Pair Corr
0.68	DYF1	Dynavax Technologies	Pair Corr
0.62	CVG	CSPC Pharmaceutical	Pair Corr
0.67	761	PHARMANUTRA SPA	Pair Corr
0.87	VTRS	Viatris Earnings Call This Week	Pair Corr
0.71	BRM	Bristol Myers Squibb	Pair Corr
0.7	ELAN	Elanco Animal Health	Pair Corr
0.62	ELVN	Enliven Therapeutics	Pair Corr

Moving against Opus Stock

0.66	21P	Aurora Cannabis	Pair Corr
0.65	BSFA	ANI Pharmaceuticals Earnings Call Tomorrow	Pair Corr
0.45	VRCA	Verrica Pharmaceuticals	Pair Corr
0.43	P52	NEWBURY PHARMACEUTICALS	Pair Corr
0.42	VM	Voyageur Pharmaceuticals	Pair Corr
0.34	IQ70	1CM INC	Pair Corr
0.32	WEED	Canopy Growth Corp	Pair Corr
0.77	EOLS	Evolus Inc Earnings Call This Week	Pair Corr
0.73	BGM	Qilian International Earnings Call This Week	Pair Corr
0.72	3ZQ0	AYURCANN HOLDINGS	Pair Corr
0.7	L1PA	LEE S PHARMACEUTICHD	Pair Corr
0.66	ACB	Aurora Cannabis	Pair Corr
0.56	BHC	Bausch Health Companies	Pair Corr
0.39	XERS	Xeris Pharmaceuticals Earnings Call This Week	Pair Corr
0.31	EYPT	Eyepoint Pharmaceuticals Earnings Call This Week	Pair Corr

Related Correlations Analysis

	COR	REGN	IDXX	HLN	CI	ELV	BDX	ELAN	ARGX	TAK
COR		0.18	-0.15	0.41	0.37	-0.34	0.39	0.52	0.15	0.35	COR
REGN	0.18		-0.3	0.59	0.69	0.17	0.48	0.48	-0.44	0.51	REGN
IDXX	-0.15	-0.3		-0.84	-0.57	0.15	-0.73	-0.55	0.43	-0.82	IDXX
HLN	0.41	0.59	-0.84		0.78	-0.07	0.85	0.81	-0.48	0.92	HLN
CI	0.37	0.69	-0.57	0.78		0.1	0.7	0.65	-0.51	0.7	CI
ELV	-0.34	0.17	0.15	-0.07	0.1		0.06	0.13	-0.68	0.06	ELV
BDX	0.39	0.48	-0.73	0.85	0.7	0.06		0.79	-0.49	0.89	BDX
ELAN	0.52	0.48	-0.55	0.81	0.65	0.13	0.79		-0.58	0.89	ELAN
ARGX	0.15	-0.44	0.43	-0.48	-0.51	-0.68	-0.49	-0.58		-0.62	ARGX
TAK	0.35	0.51	-0.82	0.92	0.7	0.06	0.89	0.89	-0.62		TAK
	COR	REGN	IDXX	HLN	CI	ELV	BDX	ELAN	ARGX	TAK

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TAK	+ 0.92	HLN
TAK	+ 0.89	BDX
TAK	+ 0.89	ELAN
BDX	+ 0.85	HLN
ELAN	+ 0.81	HLN
ELAN	+ 0.79	BDX

High negative correlations

HLN	- 0.84	IDXX
TAK	- 0.82	IDXX
BDX	- 0.73	IDXX
ARGX	- 0.68	ELV
TAK	- 0.62	ARGX
ARGX	- 0.58	ELAN

Risk-Adjusted Indicators

There is a big difference between Opus Stock performing well and Opus Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Opus Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
COR	1.17	0.01	(0.03)	0.16	2.31	(1.05)	2.01	(2.62)	10.81
REGN	1.49	0.12	0.05	0.33	1.41	(1.87)	3.40	(2.61)	8.86
IDXX	1.26	(0.19)	0.00	(0.07)	0.00	0.00	3.61	(3.18)	10.16
HLN	1.03	0.13	0.03	0.89	1.44	(1.09)	2.76	(1.81)	5.40
CI	1.22	0.01	(0.02)	0.11	1.27	(1.43)	2.64	(2.24)	7.36
ELV	1.55	(0.05)	0.00	0.06	2.87	(1.61)	3.20	(2.54)	19.95
BDX	1.21	0.20	0.19	0.31	0.70	(1.55)	3.22	(1.77)	7.13
ELAN	1.59	0.21	0.14	0.25	1.53	(1.92)	3.78	(2.79)	10.56
ARGX	1.20	(0.16)	0.00	4.32	0.00	0.00	2.29	(3.07)	7.34
TAK	0.89	0.42	0.42	10.79	0.00	(1.11)	2.49	(1.08)	4.49

Opus Genetics Corporate Management

Joseph MBA	Chief Officer	Profile
Jenny Kobin	Investor Officer	Profile
Robert Gagnon	Chief Officer	Profile
Bernhard MBA	Senior Secretary	Profile
Ashwath Jayagopal	Chief Officer	Profile
Bindu Manne	Head Commercialization	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC